Stay updated with breaking news from Esearchled Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read more about Glenmark Pharma gets approval for Theophylline Tablets on Business Standard. Glenmark Pharmaceuticals on Friday announced that it has received final approval from the USFDA for Theophylline extended release tablets.
Glenmark Pharmaceuticals on Tuesday announced the launch of Rufinamide Tablets USP, 200 mg and 400 mg. The tablets are a therapeutic equivalent of Banzel Tablets, 200 mg and 400 mg of Eisai Inc. Glenmark was one of the first ANDA applicants to submit a substantially complete ANDA for Rufinamide Tablets USP, 200 mg and 400 mg, with a paragraph IV certification and received final approval on 16 May 2016. According to IQVIA sales data for the 12-month period ending April 2021, the Banzel Tablets achieved annual sales of approximately $285.3 million. Commenting on the launch, Sanjeev Krishan, pre...
Read more about Glenmark Pharma Q4 PAT gains 6% to Rs 234 cr on Business Standard. On a consolidated basis, the drug maker's net profit rose 6.2% to Rs 233.87 crore on 4.4% increase in net sales to Rs 2,829.89 crore in Q4 March 2021 over Q4 March 2020.